Narrative review / 2012
Evidence from RCTs does not show a clear, consistent benefit of maternal or infant omega-3 supplementation on child growth, visual acuity, or neurodevelopment.
This review evaluated the effects of omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) supplementation in pregnant/lactating women and infants on child visual acuity, psychomotor development, mental performance, and growth. Across included randomized controlled trials—including 11 RCT sets during pregnancy, 2 sets during pregnancy/lactation, 3 sets during lactation, and 15 RCTs in formula-fed term infants—some reported benefits for DHA on visual acuity, long-term neurodevelopment, or growth. However, overall RCT evidence does not demonstrate a clear and consistent benefit on term infant outcomes. The authors caution that results should be interpreted carefully due to methodological limitations in the included studies.
- Study type
- Review of randomized controlled trials
- Who was studied
- Pregnant and lactating women, and term infants across multiple RCTs
- What was measured
- Infant and child growth, visual acuity, psychomotor development, and mental performance
THE PAPER
Omega 3 fatty acids on child growth, visual acuity and neurodevelopment.
Campoy C, Escolano-Margarit MV, Anjos T, Szajewska H, Uauy R. Br J Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.